582 related articles for article (PubMed ID: 24332218)
1. Efficacy of the oral chemoattractant receptor homologous molecule on TH2 cells antagonist BI 671800 in patients with seasonal allergic rhinitis.
Krug N; Gupta A; Badorrek P; Koenen R; Mueller M; Pivovarova A; Hilbert J; Wetzel K; Hohlfeld JM; Wood C
J Allergy Clin Immunol; 2014 Feb; 133(2):414-9. PubMed ID: 24332218
[TBL] [Abstract][Full Text] [Related]
2. A randomized study of BI 671800, a CRTH2 antagonist, as add-on therapy in poorly controlled asthma.
Miller D; Wood C; Bateman E; LaForce C; Blatchford J; Hilbert J; Gupta A; Fowler A
Allergy Asthma Proc; 2017 Mar; 38(2):157-164. PubMed ID: 28234053
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of a novel nasal steroid, S0597, in patients with seasonal allergic rhinitis.
Badorrek P; Hohlfeld JM; Krug N; Joshi A; Raut A
Ann Allergy Asthma Immunol; 2015 Oct; 115(4):325-329.e1. PubMed ID: 26272281
[TBL] [Abstract][Full Text] [Related]
4. The CRTH2 antagonist OC000459 reduces nasal and ocular symptoms in allergic subjects exposed to grass pollen, a randomised, placebo-controlled, double-blind trial.
Horak F; Zieglmayer P; Zieglmayer R; Lemell P; Collins LP; Hunter MG; Steiner J; Lewis T; Payton MA; Perkins CM; Pettipher R
Allergy; 2012 Dec; 67(12):1572-9. PubMed ID: 23025511
[TBL] [Abstract][Full Text] [Related]
5. Effectiveness of fluticasone furoate 110 microg once daily in the treatment of nasal and ocular symptoms of seasonal allergic rhinitis in adults and adolescents sensitized to mountain cedar pollen.
Jacobs R; Martin B; Hampel F; Toler W; Ellsworth A; Philpot E
Curr Med Res Opin; 2009 Jun; 25(6):1393-401. PubMed ID: 19419338
[TBL] [Abstract][Full Text] [Related]
6. A proof-of-concept study of the effect of a novel H3-receptor antagonist in allergen-induced nasal congestion.
Barchuk WT; Salapatek AM; Ge T; D'Angelo P; Liu X
J Allergy Clin Immunol; 2013 Oct; 132(4):838-46.e1-6. PubMed ID: 23791513
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of BI 671800, an oral CRTH2 antagonist, in poorly controlled asthma as sole controller and in the presence of inhaled corticosteroid treatment.
Hall IP; Fowler AV; Gupta A; Tetzlaff K; Nivens MC; Sarno M; Finnigan HA; Bateman ED; Rand Sutherland E
Pulm Pharmacol Ther; 2015 Jun; 32():37-44. PubMed ID: 25861737
[TBL] [Abstract][Full Text] [Related]
8. Randomized placebo-controlled trial comparing fluticasone aqueous nasal spray in mono-therapy, fluticasone plus cetirizine, fluticasone plus montelukast and cetirizine plus montelukast for seasonal allergic rhinitis.
Di Lorenzo G; Pacor ML; Pellitteri ME; Morici G; Di Gregoli A; Lo Bianco C; Ditta V; Martinelli N; Candore G; Mansueto P; Rini GB; Corrocher R; Caruso C
Clin Exp Allergy; 2004 Feb; 34(2):259-67. PubMed ID: 14987306
[TBL] [Abstract][Full Text] [Related]
9. Effect of fluticasone propionate aqueous nasal spray on allergen-induced inflammatory changes in the nasal airways of allergic rhinitics following exposure to nitrogen dioxide.
Wang JH; Devalia JL; Rusznak C; Bagnall A; Sapsford RJ; Davies RJ
Clin Exp Allergy; 1999 Feb; 29(2):234-40. PubMed ID: 10051728
[TBL] [Abstract][Full Text] [Related]
10. Once daily fluticasone furoate nasal spray is effective in seasonal allergic rhinitis caused by grass pollen.
Fokkens WJ; Jogi R; Reinartz S; Sidorenko I; Sitkauskiene B; van Oene C; Faris MA; Ellsworth A; Caldwell MF
Allergy; 2007 Sep; 62(9):1078-84. PubMed ID: 17686111
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the effects of fluticasone propionate, aqueous nasal spray and levocabastine on inflammatory cells in nasal lavage and clinical activity during the pollen season in seasonal rhinitics.
Di Lorenzo G; Gervasi F; Drago A; Esposito Pellitteri M; Di Salvo A; Cosentino D; Potestio M; Colombo A; Candore G; Mansueto S; Caruso C
Clin Exp Allergy; 1999 Oct; 29(10):1367-77. PubMed ID: 10520057
[TBL] [Abstract][Full Text] [Related]
12. Fluticasone propionate aqueous nasal spray reduces inflammatory cells in unchallenged allergic nasal mucosa: effects of single allergen challenge.
Holm A; Dijkstra M; Kleinjan A; Severijnen LA; Boks S; Mulder P; Fokkens W
J Allergy Clin Immunol; 2001 Apr; 107(4):627-33. PubMed ID: 11295650
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and onset of action of fluticasone propionate aqueous nasal spray on nasal symptoms, eosinophil count, and mediator release after nasal allergen challenge in patients with seasonal allergic rhinitis.
Wang D; Duyck F; Smitz J; Clement P
Allergy; 1998 Apr; 53(4):375-82. PubMed ID: 9574879
[TBL] [Abstract][Full Text] [Related]
14. Prophylactic effects of the histamine H1 receptor antagonist epinastine and the dual thromboxane A2 receptor and chemoattractant receptor-homologous molecule expressed on Th2 cells antagonist ramatroban on allergic rhinitis model in mice.
Suzuki Y; Inoue T; Yamamoto A; Sugimoto Y
Biol Pharm Bull; 2011; 34(4):507-10. PubMed ID: 21467637
[TBL] [Abstract][Full Text] [Related]
15. CRTH2 plays an essential role in the pathophysiology of Cry j 1-induced pollinosis in mice.
Nomiya R; Okano M; Fujiwara T; Maeda M; Kimura Y; Kino K; Yokoyama M; Hirai H; Nagata K; Hara T; Nishizaki K; Nakamura M
J Immunol; 2008 Apr; 180(8):5680-8. PubMed ID: 18390753
[TBL] [Abstract][Full Text] [Related]
16. Fluticasone furoate versus placebo in symptoms of grass-pollen allergic rhinitis induced by exposure in the Vienna Challenge Chamber.
Zieglmayer P; Zieglmayer R; Bareille P; Rousell V; Salmon E; Horak F
Curr Med Res Opin; 2008 Jun; 24(6):1833-40. PubMed ID: 18498678
[TBL] [Abstract][Full Text] [Related]
17. As-needed use of fluticasone propionate nasal spray reduces symptoms of seasonal allergic rhinitis.
Jen A; Baroody F; de Tineo M; Haney L; Blair C; Naclerio R
J Allergy Clin Immunol; 2000 Apr; 105(4):732-8. PubMed ID: 10756223
[TBL] [Abstract][Full Text] [Related]
18. Preventive effect of nasal filters on allergic rhinitis: A randomized, double-blind, placebo-controlled crossover park study.
Kenney P; Hilberg O; Laursen AC; Peel RG; Sigsgaard T
J Allergy Clin Immunol; 2015 Dec; 136(6):1566-1572.e5. PubMed ID: 26141263
[TBL] [Abstract][Full Text] [Related]
19. Effects of pollen and nasal glucocorticoid on FOXP3+, GATA-3+ and T-bet+ cells in allergic rhinitis.
Malmhäll C; Bossios A; Pullerits T; Lötvall J
Allergy; 2007 Sep; 62(9):1007-13. PubMed ID: 17686103
[TBL] [Abstract][Full Text] [Related]
20. Eosinophil markers in seasonal allergic rhinitis. Intranasal fluticasone propionate inhibits local and systemic increases during the pollen season.
Nielsen LP; Bjerke T; Christensen MB; Skamling M; Peterson CG; Mygind N; Dahl R
Allergy; 1998 Aug; 53(8):778-85. PubMed ID: 9722227
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
